Claude D. Pepper Older Americans Independence Center (P30 Clinical Trial Optional)

Claude D. Pepper 美国老年人独立中心(P30 临床试验可选)

基本信息

项目摘要

PROJECT SUMMARY OVERALL This proposal seeks to establish the Claude D Pepper Older Americans Independence Center at UConn (UConn OAIC) with the overarching goal of developing clinical strategies for enhancing function and independence in older adults that are more precise, personalized, and effective. Our focus on Precision Gerontology has emerged through the collective experiences and insights of our multidisciplinary team of accomplished investigators in the UConn Center on Aging – all united by a shared commitment to improving the lives of older adults through research, education, and clinical care. Our emphasis on Precision Gerontology has been guided by three principles: 1. A growing heterogeneity or variability over time among individuals involving all aspects of aging that therefore necessitates a multidisciplinary team-based approach to aging research; 2. Increased heterogeneity or variability with aging in older adults’ responses to treatment, highlighting the need for better targeting; and 3. Recognition of a need to incorporate these considerations into the design and testing of novel geroscience-guided therapies. These objectives will be achieved by establishing a UConn OAIC through the coordinated activities of a Leadership and Administration Core (LAC), Recruitment and Community Engagement Core (RC1), Data Resource Core (RC2), Biomarker and Preclinical Research Core (RC3), Pilot and Exploratory Studies Core (PESC), and Research Education Component (REC). We will seek to address these goals through the following aims: Aim 1: To develop and refine new approaches to the study and clinical translation of Precision Gerontology. Aim 2: To develop and evaluate new research methods, techniques, and collaborative approaches required to advance the goals of Precision Gerontology. Aim 3: To identify, develop, and learn from experiences of the next generation of researchers poised to become leaders in geriatrics research related to the UConn OAIC focus. Aim 4: To select and support innovative pilot studies that show promise in helping to guide the design, funding, and completion of more definitive future research studies related to the UConn OAIC focus.
项目总体总结 该提案旨在建立克劳德D佩珀老年美国人独立中心 在康州大学(UConn OAIC),总体目标是制定临床策略, 增强老年人的功能和独立性,使其更加精确,个性化, 有效我们对精准老年学的关注是通过集体经验而产生的 和我们的多学科团队在康州大学中心完成调查的见解, 老龄化-所有人都致力于改善老年人的生活, 研究、教育和临床护理。 我们对精确老年学的重视一直遵循三个原则:1。越来越 在涉及衰老的所有方面的个体中, 因此,需要一个多学科的团队为基础的方法来老龄化研究; 2.增加 老年人对治疗反应的异质性或变异性,突出了 需要更好的定位; 3.认识到有必要将这些考虑纳入 设计和测试新的老年科学指导疗法。 这些目标将通过建立一个UConn OAIC通过协调 领导和管理核心(LAC),招聘和社区活动 参与核心(RC 1)、数据资源核心(RC 2)、生物标志物和临床前研究 核心(RC 3),试点和探索性研究核心(PESC)和研究教育部分 (REC)。 我们将努力通过以下目标实现这些目标: 目的1:开发和完善Precision研究和临床翻译的新方法 老年学 目标2:开发和评估新的研究方法,技术和合作 推进精准老年学目标所需的方法。 目标3:识别、发展和学习下一代研究人员的经验 准备成为与康州大学OAIC重点相关的老年医学研究的领导者。 目标4:选择和支持有希望帮助指导 设计、资助和完成与以下方面有关的更明确的未来研究: UConn OAIC焦点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard H Fortinsky其他文献

Real-World Insights Into Dementia Diagnosis Trajectory and Clinical Practice Patterns Unveiled by Natural Language Processing: Development and Usability Study
通过自然语言处理揭示的痴呆症诊断轨迹和临床实践模式的真实世界见解:开发和可用性研究
  • DOI:
    10.2196/65221
  • 发表时间:
    2025-01-01
  • 期刊:
  • 影响因子:
    4.800
  • 作者:
    Hunki Paek;Richard H Fortinsky;Kyeryoung Lee;Liang-Chin Huang;Yazeed S Maghaydah;George A Kuchel;Xiaoyan Wang
  • 通讯作者:
    Xiaoyan Wang

Richard H Fortinsky的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard H Fortinsky', 18)}}的其他基金

Data Core RC2
数据核心 RC2
  • 批准号:
    10294031
  • 财政年份:
    2021
  • 资助金额:
    $ 148.41万
  • 项目类别:
Claude D. Pepper Older Americans Independence Center (P30 Clinical Trial Optional)
Claude D. Pepper 美国老年人独立中心(P30 临床试验可选)
  • 批准号:
    10668310
  • 财政年份:
    2021
  • 资助金额:
    $ 148.41万
  • 项目类别:
Data Core RC2
数据核心 RC2
  • 批准号:
    10668322
  • 财政年份:
    2021
  • 资助金额:
    $ 148.41万
  • 项目类别:
Impact of AD/ADRD on Health-Related Outcomes in a Statewide Population Enrolled in a Publicly-Funded HCBS Waiver Program for Older Adults
AD/ADRD 对参加公共资助的老年人 HCBS 豁免计划的全州人口健康相关结果的影响
  • 批准号:
    10095054
  • 财政年份:
    2020
  • 资助金额:
    $ 148.41万
  • 项目类别:
Translation of COPE for Publicly-Funded Home Care Clients and their Families
为公共资助的家庭护理客户及其家人提供 COPE 翻译
  • 批准号:
    9105676
  • 财政年份:
    2014
  • 资助金额:
    $ 148.41万
  • 项目类别:
Translation of COPE for Publicly-Funded Home Care Clients and their Families
为公共资助的家庭护理客户及其家人提供 COPE 翻译
  • 批准号:
    8696260
  • 财政年份:
    2014
  • 资助金额:
    $ 148.41万
  • 项目类别:
Translation of COPE for Publicly-Funded Home Care Clients and their Families
为公共资助的家庭护理客户及其家人提供 COPE 翻译
  • 批准号:
    8895825
  • 财政年份:
    2014
  • 资助金额:
    $ 148.41万
  • 项目类别:
Proactive Primary Dementia Care
积极主动的原发性痴呆护理
  • 批准号:
    7897932
  • 财政年份:
    2009
  • 资助金额:
    $ 148.41万
  • 项目类别:
RESOURCE USE AND PATIENT OUTCOMES IN MEDICARE HOME CARE
医疗保险家庭护理中的资源使用和患者结果
  • 批准号:
    6040884
  • 财政年份:
    1999
  • 资助金额:
    $ 148.41万
  • 项目类别:
RESOURCE USE AND PATIENT OUTCOMES IN MEDICARE HOME CARE
医疗保险家庭护理中的资源使用和患者结果
  • 批准号:
    6187610
  • 财政年份:
    1999
  • 资助金额:
    $ 148.41万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 148.41万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 148.41万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 148.41万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 148.41万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 148.41万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 148.41万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 148.41万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 148.41万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 148.41万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 148.41万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了